Integra LifeSciences Holdings Corporation (IART) — 分析师展望 / 分析师共识目标价为. 基于 26 位分析师评级, 共识为 看涨 — 12 买入, 9 持有, 5 卖出.
分析师共识目标价为 $15.00, 上涨空间为 35.6% 相对于当前价格 $11.06.
分析师预估 每股收益(EPS)为 $2.45 和 营收为 $1.61B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.09 vs 预期 $2.45 (不及预期 -103.7%). 2025: 实际 $-6.73 vs 预期 $2.20 (不及预期 -405.7%). 分析师准确度: 0%.
IART 股票 — 12个月价格预测
$15.00
▲ +35.62% 上涨空间
平均目标价
Based on 26 Wall Street analysts offering 12-month price targets for Integra LifeSciences Holdings Corporation, the price target is $15.00.
平均目标价相对最新价格 $11.06 变动 +35.62%。
IART 分析师评级
Buy
基于过去3个月内 26 位分析师对 Integra LifeSciences Holdings Corporation 的评级
EPS 预测 — IART
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.09
vs Est $2.45
▼ 2,823.9% off
2025
Actual –$6.73
vs Est $2.20
▼ 132.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.
营收预测 — IART
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $1.611B
vs Est $1.613B
▼ 0.2% off
2025
Actual $1.635B
vs Est $1.630B
▲ 0.3% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
